Navigation Links
Consortium publishes Phase II map of human genetic variation
Date:10/17/2007

The International HapMap Consortium today published analyses of its second-generation map of human genetic variation, which contains three times more markers than the initial version unveiled in 2005. In two papers in the journal Nature, the consortium describes how the higher resolution map offers greater power to detect genetic variants involved in common diseases, explore the structure of human genetic variation and learn how environmental factors, such as infectious agents, have shaped the human genome.

Any two humans are more than 99 percent the same at the genetic level. However, it is important to understand the small fraction of genetic material that varies among people because it can help explain individual differences in susceptibility to disease, response to drugs or reaction to environmental factors. Variation in the human genome is organized into local neighborhoods called haplotypes, which usually are inherited as intact blocks of information. Consequently, researchers refer to the map of human genetic variation as a haplotype map, or HapMap.

The International HapMap Consortium is a public-private partnership of researchers and funding agencies from Canada, China, Japan, Nigeria, the United Kingdom and the United States. The U.S. component of the project is led by the National Human Genome Research Institute (NHGRI) on behalf of the 20 institutes, centers and offices of the National Institutes of Health (NIH) that contributed funding.

Thanks to this consortiums pioneering efforts to map human genetic variation, we are already seeing a windfall of results that are shedding new light on the complex genetics of common diseases, said NHGRI Director Francis S. Collins, M.D., Ph.D. This new approach to research, called genome-wide association studies, has recently uncovered new clues to the genetic factors involved in type 2 diabetes, cardiovascular disease, prostate cancer, multiple sclerosis and many other disorders. These
'/>"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology technology :

1. Research consortium aims to bring security and defense contracts to Wisconsin
2. Wisconsin consortium aims for defense business
3. Doyle announces biobased energy consortium
4. E-business consortium evaluates 12 desktop search engines
5. University Consortium Enables Transformation and Survival for Wisconsin Businesses
6. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
7. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
8. Easy preparation of total RNA from cultured cells with TRIzol and Eppendorf Phase Lock Gel
9. Identification of cells in S phase using the Cell Proliferation Fluorescence Kit and IN Cell Analyzer 1000
10. Direct Monitoring of Solid-Phase Peptide Synthesis by MALDI-TOF MS
11. Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...cative new study, a University of Utah scientist a...jor cause of global warming cannot be stabilized ...ilds the equivalent of one new nuclear power plant... be any substantial near-term departure from recen...on rates," says the new paper by Tim Garrett, an a...
(Date:11/23/2009)...unication, computation and more powerful ways to e...antum states as carriers of information is an extr...hown, mathematically, how to gently tease out unwa... the information intact. Their work is reported in...d highlighted with a Viewpoint in Physics ( http...
(Date:11/23/2009)...e-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI ...2009astheex-dividenddateforits$200millionspecialdi...transactioncompletedonNovember2,2009.Thedividendwi...ontherecorddate,December1,2009.NASDAQhassettheappr...fcommonstockforpurposesoftheex-dividenddateonNovem...
(Date:11/23/2009)...tCall/--NeogenCorporation(Nasdaq: NEOG )announcedt...sBoardofDirectorsatthecompany,srecentannualmeeting...xperienceinthefood,agriculture,andtradeindustriesa...leconomicsatVirginiaTechUniversity.FromJanuary2006...enegotiatorwiththerankofambassador. ,, "Sinceou...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2
...erMune, Inc.,(Nasdaq: ITMN ) today announced tha...er and President of InterMune, will present at the...San Francisco on January 15, 2009 at 1:00 p.m.,PST...entation, investors and other,interested parties m...une,s,corporate website at http://www.intermune.c...
...do Biosciences, Inc. announced today that David J....er, will be presenting at the 27th Annual J.P. Mor...Wednesday, January 14, 2009, at 11:30am Pacific Ti...n will include a review of the Company,s lead comp... and enterprise-level business initiatives. , , ...
...AND, New Zealand, Jan. 6 MicroDose Technologies, ...hey have entered into a collaboration to investiga...) technology with MicroDose,s next generation elec...of the agreement, MicroDose will fund the developm...latform and incorporating Nexus6,s SmartinhalerLiv...
Other Biology Technology:MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3
(Date:11/23/2009)...ber 16, 2009 -- A USDOE and USDA study concluded t...nd, and cropland pasture could be converted from c..., such as switchgrass, from which biomass could be...cally viable production of a perennial grass monoc...s are removed annually is expected to require nitr...
(Date:11/23/2009)...uthern California biomedical engineer and cardiolo...l to help clinicians distinguish cardiac emergenci...ms manageable with drugs and lifestyle change. , ...o the arteries feeding the heart, offer an inside ...ood vessels, often revealing deposits of a dangero...
(Date:11/23/2009)...tute of General Medical Sciences (NIGMS), part of ...ing $42.3 million for grants in scientific areas i...veloped the GO grant program to stimulate biomedic...y the American Recovery and Reinvestment Act (Reco...romise to have a significant impact on a field of ...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 1ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 4US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 1US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 2US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 3
...s release is available in German . , , It has a...zation determines the shape of precious stones, bu...How this comes about, has been known for a long ti...tute of Colloids and Interfaces are now whittling ... explain numerous phenomena. The researchers inves...
...s release is available in German . , , A joint ..., Spain) and the Max Planck Institutes of Biochemi...he non-invasive and nanoscale resolved infrared ma...od, which is based on near-field microscopy, opens...f high-performance materials or for contact-free m...
...UMBUS, Ohio) A new strategy developed in the Neon...nwide Children,s Hospital is helping premature inf...ficulties learn to feed on their own. According to...ournal of Pediatric Gastroenterology and Nutrition...o help 15 out of 20 infants with severe feeding di...
Other Biology News:A crystal clear view of chalk formation 2A crystal clear view of chalk formation 3A crystal clear view of chalk formation 4Tension in the nanoworld 2Crib-side studies help struggling newborns go home without feeding tubes 2Crib-side studies help struggling newborns go home without feeding tubes 3
...your samples with eArray and Agilents custom print... create your own microarray designs that meet your...e and receive delivery of your arrays in weeks, an...ray creation application tool that enables you to ...
...utine trace metal analytical lab that require high...se instrumentation. The 7500ce offers unmatched de...ces found in the environmental industry. It is equ...found in the clinical, foods, petrochemical, metal...
Mouse Anti-Polio component type I Monoclonal Antibody, Unconjugated, Clone 9B4 from AntibodyShop A/S
Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
Biology Products: